Latest "Biomarker discovery Driving technologies" News Stories

21:38 EST 29th January 2015 | BioPortfolio

Here are the most relevant search results for "Biomarker discovery Driving technologies" found in our extensive news archives from over 250 global news sources.

More Information about Biomarker discovery Driving technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biomarker discovery Driving technologies for you to read. Along with our medical data and news we also list Biomarker discovery Driving technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biomarker discovery Driving technologies Companies for you to search.

Showing "Biomarker discovery Driving technologies" News Articles 1–25 of 7,300+

Relevant

Enhancing Blood Biomarker Discovery for Better Disease Diagnostics

A two-year grant from the National Institutes of Health will fund work by a Purdue Research Park-based company to improve methods to screen blood plasma samples for biomarkers, which are measurable indicators of a disease, to expedite diagnosis and t...

Biomarker firm obtains $2.3M in funding for autism study

The Nancy Lurie Marks Family Foundation has given Stemina Biomarker Discovery $2.3 million to finance its study of autism spe -More- 

Thyroid carcinoma: Biomarker reveals cancer cause

The expression of the protein CLIP2 provides information on whether a papillary thyroid carcinoma was induced by radiation or had a sporadic origin. With this discovery, scientists have identified a new biomarker for the diagnosis of the cancer cause...

Biomarker reveals cause of thyroid carcinoma

The expression of the protein CLIP2 provides information on whether a papillary thyroid carcinoma was induced by radiation or had a sporadic origin. With this discovery, scientists from the Helmholtz Zentrum München have identified a new biomarker f...

Biomarker discovery sheds new light on heart attack risk of arthritis drugs

A class of drug for treating arthritis - all but shelved over fears about side effects - may be given a new lease of life, following the discovery of a possible way to identify which patients should avoid using it.

Biomarkers Summit March 18-20,2015 San Diego, CA

The Biomarker Summit 2015, to be held on March 18-20, 2015 in San Diego, CA at the Westin San Diego Hotel, is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarke...

Cypher Genomics And Illumina, Inc. Enter Agreement To Facilitate Genomic Biomarker Discovery

Almac Launches Next-Gen Biomarker Assay

P53 sequencing test available for cancer drug discovery

The Role of Biomarkers in the Fight Against Cancer

To celebrate the dramatic increase in the discovery and application of biomarkers, and their major role in current drug development, Thomson Reuters last week announced and released the one millionth use line record from the Biomarker content within Integrity. This milestone is best understood when placed in context to how biomarker information such as this […] The post The Role of Biomarker...

A biomarker as indicator for the likelihood of developing aggressive prostate cancer

Overexpression of the protein BAZ2A, which leads to alterations in epigenetic patterns, increases the malignant properties of tumour cells, including their mobility and their ability to form metastases. The findings of a team of researchers from Heidelberg, Zurich and Hamburg may have led to the discovery of an urgently needed prognostic biomarker that would make it possible to differentiate aggre...

07.28.14 -- Scientists Report Discovery Of Biomarker For HIV Vaccine; Teva Acquires Labrys

07/28/14 Bioresearch Online Newsletter

Aggressive Breast Cancer Biomarker Identified

Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a sma...

A novel biomarker for mutant p53 could help pathologists assessing tumors during surgery

(Cold Spring Harbor Laboratory) Researchers at Cold Spring Harbor Laboratory today report the discovery of a novel cellular biomarker that could make it comparatively easy for cancer surgeons to determine if a patient has a potentially lethal mutatio...

Distracted Driving is Deadly Driving: Journeyworks Publishing Announces New Pamphlet "Texting and Driving: 10 Things Everyone Needs to Know"

Santa Cruz, CA (PRWEB) September 09, 2014 Who are the most frequent offenders of talking on a cellphone while driving? Teens. Who are they talking to? Their parents. We know being distracted by our cell phones while driving is dangerous, but what ...

Tissue Phenomics(TM): From Biomarker Discovery to Clinical Diagnostic Assay Commercialization, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - September 08, 2014) - In this webinar, Dr. Thomas Nifong, Executive Vice President of Diagnostic Tests at Definiens, will be providing an overview of Tissue Phenomics™ and how the platform supports improved biomarker discovery on through to clinical diagnostic assay commercialization. There will be two live broadcasts on Tuesday, September 23rd, at 1pm BST (UK/ GMT ...

Drug discovery in paediatric oncology: roadblocks to progress

In this Viewpoint, four key opinion leaders discuss the slow rate of drug development in paediatric oncology, which must be addressed in a meaningful way if we are to make progress. They discuss a range of aspects, from clinical trial design and biom...

Cypher Genomics Announces the Appointment of Adam Simpson as President and COO

The company provides rapid and comprehensive annotation and interpretation of individual human genomes for biomarker discovery and clinical reporting.

Biomarker in aggressive breast cancer identified

Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a sma...

New biomarker for iron regulator-related diseases and cancer

Dr. Hung-Jen Wu, assistant professor of chemical engineering at Texas A&M University, connects industrial processes of membrane separation and molecular sieve technology to identify a new biomarker for iron regulator-related diseases and cancer. The ...

Coming soon: Self-driving hospital beds?

By now, most people have heard of the concept of self-driving cars. That’s perhaps in the not-too-distant future. But in the nearer term, there very well could be self-driving hospitals...

Next generation biomarker detects tumour cells and delivers anti-cancer drugs

Nanyang Technological University (NTU) has invented a unique biomarker with two exceptional functions.

Pragmatic issues in biomarker evaluation for targeted therapies in cancer

Biomarkers that predict a patient's responsiveness to anticancer therapies are of increasing importance during drug development and in clinical trials, as well as in the clinic. In this Review, the major challenges to biomarker development and standa...

Cancer Biomarker and Drug Delivery System in One

Next generation biomarker detects tumor cells and delivers anti-cancer drugsRead more about Cancer Biomarker and Drug Delivery System in OneComments

Marketresearchreports.biz: Rising Prevalence of Cancer Driving the Global and US Cancer Biomarker Market to 2018

Marketresearchreports.biz has announced the addition of the “Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)” report to their offering. Albany, NY (PRWEB) December 09, 2014 This report is a study of the global oncogenic or canc...

Merrimack Pharmaceuticals Presents Additional Phase 2 Biomarker Data Further Strengthening the Finding That MM-121 Increases Progression Free Survival in Patients With Biomarker Positive Metastatic Breast Cancer

Data Presented as Part of Meta-Analysis Showing MM-121's Favorable Impact on Progression Free Survival in 38-54 Percent of Patients With Ovarian, Lung and Breast Cancers Across Three Phase 2 Studies Clinical and Biomarker Data From Phase 1 Studies of MM-151 and MM-111 Presented; MM-151 Wins "Best Poster" in Developmental Therapeutics Poster Session MADRID, Spain, Sept. 30, 2014 (GLOBE NEWSW...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks